A Randomized, Prospective Study of the Efficacy, Safety and Tolerability of Two Doses of GW433908Ritonavir Given With Abacavir/Lamivudine Fixed Dose Combination

NCT00335270 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

HIV

Interventions

DRUG: fos-amprenavir calcium, ritonavir
DRUG: abacavir/lamivudine as Epzicom

Sponsor

Duke University

Collaborators

[object Object]